Clinical trial
SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting…
NCT00180453 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00180453 |
|---|---|
| Title | SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System |
| Official title | SPIRIT First: A Clinical Evaluation of an Investigational Device. The Abbott XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Native Coronary Artery Lesions |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease, Everolimus, Vascular Disease, Myocardial Ischemia, Coronary Artery Stenosis |
| Intervention type | Device |
| Interventions | Coronary artery drug eluting stent placement, Coronary artery stent placement |
| Enrollment | 60 |
| Start date | Dec 1, 2003 |
| Primary completion | Apr 1, 2005 |
| Completion | Jun 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Jan 6, 2010 |
| Countries | Denmark, Germany, Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: